On September 25, 2024, Intelligent Bio Solutions' Compensation Committee granted special one-time stock awards to two key executives as part of the company's 2024 compensation analysis and evaluation. CEO Harry Simeonidis received 40,000 fully vested common shares valued at $76,400, while CFO Spiro Sakiris was awarded 34,500 fully vested common shares worth $65,895.The stock valuations were based on the company's closing share price on September 25, 2024. The Compensation Committee, consisting entirely of independent directors, approved these executive compensation grants.

On September 25, 2024, Intelligent Bio Solutions' Compensation Committee granted special one-time stock awards to two key executives as part of the company's 2024 compensation analysis and evaluation. CEO Harry Simeonidis received 40,000 fully vested common shares valued at $76,400, while CFO Spiro Sakiris was awarded 34,500 fully vested common shares worth $65,895.The stock valuations were based on the company's closing share price on September 25, 2024. The Compensation Committee, consisting entirely of independent directors, approved these executive compensation grants.